LU85721A1 - Compose antibiotique,procede pour le preparer et compositions le contenant - Google Patents

Compose antibiotique,procede pour le preparer et compositions le contenant Download PDF

Info

Publication number
LU85721A1
LU85721A1 LU85721A LU85721A LU85721A1 LU 85721 A1 LU85721 A1 LU 85721A1 LU 85721 A LU85721 A LU 85721A LU 85721 A LU85721 A LU 85721A LU 85721 A1 LU85721 A1 LU 85721A1
Authority
LU
Luxembourg
Prior art keywords
stearate
erythromycin
acetyl
erythromycin stearate
same
Prior art date
Application number
LU85721A
Other languages
English (en)
French (fr)
Inventor
Martti L A Marvola
Esko V Marttila
Jaakko A Uotila
Aino K Pippuri
Pekka J Kairisalo
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of LU85721A1 publication Critical patent/LU85721A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
LU85721A 1984-01-06 1985-01-04 Compose antibiotique,procede pour le preparer et compositions le contenant LU85721A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK5884 1984-01-06
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (1)

Publication Number Publication Date
LU85721A1 true LU85721A1 (fr) 1985-07-24

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85721A LU85721A1 (fr) 1984-01-06 1985-01-04 Compose antibiotique,procede pour le preparer et compositions le contenant

Country Status (38)

Country Link
US (1) US4599326A (it)
JP (1) JPS60158197A (it)
KR (1) KR900006237B1 (it)
AT (1) AT386414B (it)
AU (1) AU565688B2 (it)
BE (1) BE901411A (it)
BG (1) BG43189A3 (it)
CA (1) CA1224461A (it)
CH (1) CH666275A5 (it)
CS (1) CS247191B2 (it)
CY (1) CY1462A (it)
DE (1) DE3500179A1 (it)
DK (1) DK149776C (it)
ES (1) ES8605818A1 (it)
FI (1) FI77249C (it)
FR (1) FR2557878B1 (it)
GB (1) GB2152502B (it)
HK (1) HK11590A (it)
HU (1) HU196221B (it)
IE (1) IE57967B1 (it)
IL (1) IL73885A (it)
IS (1) IS2968A7 (it)
IT (1) IT1184304B (it)
KE (1) KE3841A (it)
LU (1) LU85721A1 (it)
MA (1) MA20316A1 (it)
MX (1) MX156277A (it)
NL (1) NL8403979A (it)
NO (1) NO160263C (it)
NZ (1) NZ210606A (it)
PH (1) PH22471A (it)
PL (1) PL144349B1 (it)
PT (1) PT79777B (it)
RO (1) RO91262B (it)
SE (1) SE461854B (it)
SU (1) SU1410866A3 (it)
YU (1) YU44485B (it)
ZA (1) ZA8410143B (it)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
AU2003247876B2 (en) * 2002-07-05 2006-10-05 Collegium Pharmaceutical, Inc Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US20050163841A1 (en) * 2003-10-31 2005-07-28 Wong Patrick S. Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid
WO2005123039A1 (en) 2004-06-12 2005-12-29 Collegium Pharmaceutical, Inc. Abuse-deterrent drug formulations
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
EP2457580A1 (en) 2004-08-25 2012-05-30 The UAB Research Foundation Absorption enhancers for drug administration
CA2714867A1 (en) 2006-06-23 2007-12-27 Candace B. Pert Non-aggregated pharmaceutically active peptide
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CA2836573C (en) 2011-05-18 2022-06-07 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
ES2906975T3 (es) 2012-11-20 2022-04-21 Eumederis Pharmaceuticals Inc Productos farmacéuticos de péptidos mejorados
US11065304B2 (en) 2012-11-20 2021-07-20 Mederis Diabetes, Llc Peptide pharmaceuticals for insulin resistance
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
CN113264994A (zh) 2014-05-28 2021-08-17 梅德瑞斯糖尿病有限责任公司 针对胰岛素抵抗的改良肽药物
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations
WO2018213751A1 (en) * 2017-05-19 2018-11-22 Lunella Biotech, Inc. Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
CA3083487A1 (en) 2017-12-01 2019-06-06 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
CN116549389A (zh) 2018-02-06 2023-08-08 爱奇司治疗公司 鼻内肾上腺素制剂及治疗疾病的方法
JP6941224B2 (ja) 2018-02-06 2021-09-29 イージス セラピューティクス，エルエルシー 疾患の処置のための鼻腔内エピネフリン製剤及び方法
CA3123850A1 (en) * 2018-12-17 2020-06-25 Lunella Biotech, Inc. Triple combination therapies for anti-aging
CA3123838A1 (en) * 2018-12-17 2020-06-25 Lunella Biotech, Inc. Triple combination therapies for targeting mitochondria and killing cancer stem cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
DK149776C (da) 1987-04-21
CS247191B2 (en) 1986-12-18
FI850023L (fi) 1985-07-07
SE461854B (sv) 1990-04-02
PT79777B (en) 1986-10-21
IE57967B1 (en) 1993-06-02
YU44485B (en) 1990-08-31
MX156277A (es) 1988-08-04
BE901411A (fr) 1985-04-16
SU1410866A3 (ru) 1988-07-15
ES8605818A1 (es) 1986-04-01
AU3705984A (en) 1985-07-11
RO91262B (ro) 1987-07-01
DE3500179C2 (it) 1989-08-24
IT8519012A0 (it) 1985-01-04
FI77249C (fi) 1989-02-10
GB8432368D0 (en) 1985-02-06
HU196221B (en) 1988-10-28
HK11590A (en) 1990-02-23
CA1224461A (en) 1987-07-21
DK5884A (da) 1985-07-07
ZA8410143B (en) 1985-08-28
NO850007L (no) 1985-07-08
GB2152502B (en) 1987-10-07
SE8406671D0 (sv) 1984-12-28
IL73885A0 (en) 1985-03-31
JPS60158197A (ja) 1985-08-19
KE3841A (en) 1989-04-07
SE8406671L (sv) 1985-07-07
IS2968A7 (is) 1985-04-03
BG43189A3 (en) 1988-04-15
NO160263B (no) 1988-12-19
ATA985A (de) 1988-01-15
PL144349B1 (en) 1988-05-31
PH22471A (en) 1988-09-12
CY1462A (en) 1989-07-21
GB2152502A (en) 1985-08-07
FI850023A0 (fi) 1985-01-03
DK149776B (da) 1986-09-29
AT386414B (de) 1988-08-25
HUT37628A (en) 1986-01-23
DK5884D0 (da) 1984-01-06
NZ210606A (en) 1987-08-31
PL251457A1 (en) 1985-11-05
CH666275A5 (de) 1988-07-15
KR900006237B1 (ko) 1990-08-27
US4599326A (en) 1986-07-08
NO160263C (no) 1989-03-29
FR2557878A1 (fr) 1985-07-12
NL8403979A (nl) 1985-08-01
IL73885A (en) 1988-10-31
MA20316A1 (fr) 1985-10-01
PT79777A (en) 1985-01-01
DE3500179A1 (de) 1985-07-18
AU565688B2 (en) 1987-09-24
YU2085A (en) 1987-12-31
JPH029040B2 (it) 1990-02-28
KR850005452A (ko) 1985-08-26
FR2557878B1 (fr) 1988-01-15
ES539349A0 (es) 1986-04-01
FI77249B (fi) 1988-10-31
IE850022L (en) 1985-07-06
RO91262A (ro) 1987-06-30
IT1184304B (it) 1987-10-28

Similar Documents

Publication Publication Date Title
LU85721A1 (fr) Compose antibiotique,procede pour le preparer et compositions le contenant
CN103228668B (zh) 抗糖尿病的苯基丙酮酸烯醇糖苷
BE1000573A4 (fr) Derives de 1-(hydroxystyryl)-5h-2,3-benzodiazepine, procede pour les preparer et compositions pharmaceutiques les contenant.
FR2495160A1 (fr) Derive de bisglucosylmoranoline et compositions pharmaceutiques pour le traitement du diabete sucre qui le renferment
LU84428A1 (fr) Nouveaux derives de l'acide 4-phenyl 4-oxo 2-butenoique,leurs sels,leur preparation,leur application comme medicaments et les compositions les renfermant
CA1181340A (fr) Compositions pharmaceutiques renfermant des derives de l'acide 4-phenyl-4-oxo 2-butenoique
CA1199582A (fr) Forme medicamenteuse de theophylline a action prolongee
EP0117171B1 (fr) Dérivés aminés de la pyridazine substitués en position 6 par un hétérocycle ou un alicycle, procédé d'obtention et médicaments les contenant
CA2075291C (fr) Nouvel agent antitumoral derive du dextrane
FR2547821A1 (fr) Sel de 2-piperazinopyrimidine, procede pour sa preparation et compositions pharmaceutiques en contenant
WO1981002295A1 (fr) Phenoxyisobutyrates de moroxydine et medicaments les contenant
FR2801055A1 (fr) Derives de beta-d-5-thioxylose, procede de preparation et utilisation en therapeutique
EP0155872A1 (fr) Procédé de réduction du taux de lignine dans les végétaux et nouvelles compositions pour sa mise en oeuvre
EP1007522B1 (fr) 2- 4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluoropyrimidine, sa preparation et son utilisation therapeutique
FR2471984A1 (fr) Derives de l'acide aminobenzoique et leur utilisation pour preparer des compositions pharmaceutiques
BE875451A (fr) Nouveaux medicaments constitues de derives de l'acide p-amino-benzoique
CN116265463A (zh) 一种醛糖还原酶抑制剂的晶型及其制备方法和应用
FR2619010A1 (fr) Composition pharmaceutique antivirale comprenant de la 5-isopropyl-2'-b-deoxyuridine, s'accumulant dans la peau, applicable par voie externe et procede pour sa preparation
CN116157120A (zh) 包含苯并呋喃基n-酰腙衍生物的抗炎组合物
BE880713A (fr) Nouvelles compositions pharmaceutiques solides a base d'alcaloides de l'ergot de seigle, permettant une liberation controlee de ce principe actif
JPH0959249A (ja) 抗菌剤及び医薬組成物
CA2127545A1 (fr) Nouvelle application therapeutique de derives de pyridylpyrrolothiazole carboxamide
CN114097804A (zh) 一种二氨基嘧啶类化合物在防治农业病原菌中的用途
BE572026A (it)
BE633874A (it)